JP2020512292A - リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 - Google Patents
リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 Download PDFInfo
- Publication number
- JP2020512292A JP2020512292A JP2019533167A JP2019533167A JP2020512292A JP 2020512292 A JP2020512292 A JP 2020512292A JP 2019533167 A JP2019533167 A JP 2019533167A JP 2019533167 A JP2019533167 A JP 2019533167A JP 2020512292 A JP2020512292 A JP 2020512292A
- Authority
- JP
- Japan
- Prior art keywords
- linaclotide
- week
- pain
- composition
- baseline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022073214A JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662437566P | 2016-12-21 | 2016-12-21 | |
US62/437,566 | 2016-12-21 | ||
PCT/US2017/067814 WO2018119191A1 (en) | 2016-12-21 | 2017-12-21 | Methods of treating irritable bowel syndrome with modified or delayed release formulations of linaclotide |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022073214A Division JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020512292A true JP2020512292A (ja) | 2020-04-23 |
JP2020512292A5 JP2020512292A5 (zh) | 2021-02-04 |
Family
ID=61022424
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019533167A Pending JP2020512292A (ja) | 2016-12-21 | 2017-12-21 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
JP2022073214A Pending JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022073214A Pending JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3558337A1 (zh) |
JP (2) | JP2020512292A (zh) |
CN (1) | CN110475564A (zh) |
AU (1) | AU2017379082A1 (zh) |
BR (1) | BR112019012689A2 (zh) |
CA (1) | CA3048195A1 (zh) |
EA (1) | EA201991531A1 (zh) |
MA (1) | MA47112A (zh) |
MX (2) | MX2019007574A (zh) |
WO (1) | WO2018119191A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118105461A (zh) * | 2019-06-10 | 2024-05-31 | 硬木药品公司 | 治疗与腹泻占主导的肠易激综合征相关的腹部疼痛 |
CA3238619A1 (en) * | 2021-11-29 | 2023-06-01 | Michael Gerber | Pharmaceutical compositions for the treatment of visceral pain |
WO2023196821A2 (en) * | 2022-04-04 | 2023-10-12 | Thomas Jefferson University | Targeting neuropod cell gucy2c to control visceral pain and appetite |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016197042A1 (en) * | 2015-06-05 | 2016-12-08 | Ironwood Pharmaceuticals, Inc. | Modified or targeted release formulations of linaclotide |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
WO2010019266A2 (en) | 2008-08-15 | 2010-02-18 | Ironwood Pharmaceuticals, Inc. | Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration |
EP2464373A1 (en) * | 2009-08-13 | 2012-06-20 | Ironwood Pharmaceuticals, Inc. | Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists |
DK2536742T3 (en) | 2010-02-17 | 2017-09-04 | Ironwood Pharmaceuticals Inc | TREATMENTS FOR GASTROINTESTINAL DISORDERS |
US20140005128A1 (en) * | 2010-08-11 | 2014-01-02 | Forest Laboratories Holdings Limited | Treatments of gastrointestinal disorders |
WO2013025969A1 (en) | 2011-08-17 | 2013-02-21 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
CN108057028A (zh) * | 2013-01-15 | 2018-05-22 | 铁木医药有限公司 | 片剂形式的肠溶包衣的胃内滞留口服剂型及其应用和药物组合物 |
UA119335C2 (uk) * | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Композиції лінаклотиду з затриманим вивільненням |
-
2017
- 2017-12-21 EP EP17833050.2A patent/EP3558337A1/en active Pending
- 2017-12-21 BR BR112019012689-9A patent/BR112019012689A2/pt unknown
- 2017-12-21 MA MA047112A patent/MA47112A/fr unknown
- 2017-12-21 AU AU2017379082A patent/AU2017379082A1/en active Pending
- 2017-12-21 CN CN201780087073.0A patent/CN110475564A/zh active Pending
- 2017-12-21 WO PCT/US2017/067814 patent/WO2018119191A1/en unknown
- 2017-12-21 MX MX2019007574A patent/MX2019007574A/es unknown
- 2017-12-21 CA CA3048195A patent/CA3048195A1/en active Pending
- 2017-12-21 JP JP2019533167A patent/JP2020512292A/ja active Pending
- 2017-12-21 EA EA201991531A patent/EA201991531A1/ru unknown
-
2019
- 2019-06-21 MX MX2023008839A patent/MX2023008839A/es unknown
-
2022
- 2022-04-27 JP JP2022073214A patent/JP2022093472A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016197042A1 (en) * | 2015-06-05 | 2016-12-08 | Ironwood Pharmaceuticals, Inc. | Modified or targeted release formulations of linaclotide |
Non-Patent Citations (3)
Title |
---|
GASTROENTEROLOGY, 2017.4, VOL.152, NO.5, SUPPL.1, PP.S1314-S1315, JPN6021042902, ISSN: 0004626070 * |
STUDY NCT02559206 SUBMITTED DATE: JULY 22, 2016 (V3),CLINICALTRIALS.GOV ARCHIVE[ONLINE],2016年7月2, JPN6021042901, ISSN: 0004626069 * |
THE AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020.10, VOL.116, PP.354-361, JPN6021042903, ISSN: 0004626071 * |
Also Published As
Publication number | Publication date |
---|---|
JP2022093472A (ja) | 2022-06-23 |
MA47112A (fr) | 2019-10-30 |
BR112019012689A2 (pt) | 2019-11-19 |
EP3558337A1 (en) | 2019-10-30 |
AU2017379082A1 (en) | 2019-07-04 |
CA3048195A1 (en) | 2018-06-28 |
MX2023008839A (es) | 2023-08-14 |
CN110475564A (zh) | 2019-11-19 |
WO2018119191A1 (en) | 2018-06-28 |
WO2018119191A9 (en) | 2018-10-18 |
MX2019007574A (es) | 2019-09-04 |
EA201991531A1 (ru) | 2019-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7483656B2 (ja) | リナクロチドの遅延放出組成物 | |
JP2022093472A (ja) | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 | |
US20220202725A1 (en) | Modified or Targeted Release Formulations of Linaclotide | |
US20230142270A1 (en) | Delayed Release Compositions of Linaclotide | |
US20230346878A1 (en) | Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome | |
BR112016013419B1 (pt) | Composições de liberação retardada compreendendo um comprimido com revestimento entérico, forma de dosagem unitária e uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201218 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201218 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211028 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220124 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220322 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220516 |